Company / Net Income
Outlook Therapeutics, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$75.4M
FY2025
5-year range
-$75.4M / -$30.1M
FY2021-FY2025
Trend
-118.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$30M to -$75M over the past 6 years.
Based on SEC 10-K filings.
-$75M in FY2025.
Declined from -$30M to -$75M over the past 6 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 118.3% year-over-year.
- Peak net income was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$75.4M | -118.3% |
| FY2020 | -$34.5M | -14.7% |
| FY2019 | -$30.1M | +22.5% |
| FY2018 | -$38.8M | +27.1% |
| FY2017 | -$53.3M | -12.5% |
| FY2016 | -$47.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026